date:Jun 18, 2013
rbonate, F.A.S.T. offers a liquid format of relief from maladies that are typically treated with medications like Goodys or TUMS. The product is expected to retail for $2.99 per shot.
While unconventional in the U.S., Platernik said this is an underdeveloped category thats succeeded in Japan. Sofinnova Ventures, an investment firm with 40 years of healthcare experience, rewarded Platerinks faith last month with an investment that will help launch F.A.S.T. this August.
We believe the consumer h